IMUGENE CHART. TA only, page-17223

I know I'm on the wrong thread but for what it's worth I think the next couple of days will be intriguing in terms of what we've got coming up . Imugene has clinical collaborations with Merck/ Pfizer, Roche Genentech, Celularity, Eureka , city of Hope and with all these companies there is a substantial amount of money at their disposal. We have no idea what the data looks like atm but I think if they are looking positive, any number of people who have access to this information can use it to their advantage. Hence why I believe that we've had a couple of tree shakes happening cause who wouldn't want to buy cheaper shares in a company that is looking like doing great things . Rant over but I think there are plenty of games being played this week